These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31487266)

  • 61. Functional role of the soluble guanylyl cyclase alpha(1) subunit in vascular smooth muscle relaxation.
    Nimmegeers S; Sips P; Buys E; Brouckaert P; Van de Voorde J
    Cardiovasc Res; 2007 Oct; 76(1):149-59. PubMed ID: 17610859
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The molecular mechanism of heme loss from oxidized soluble guanylate cyclase induced by conformational change.
    Pan J; Zhang X; Yuan H; Xu Q; Zhang H; Zhou Y; Huang ZX; Tan X
    Biochim Biophys Acta; 2016 May; 1864(5):488-500. PubMed ID: 26876536
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Therapeutic potential of soluble guanylate cyclase modulators in neonatal chronic lung disease.
    Wagenaar GT; Hiemstra PS; Gosens R
    Am J Physiol Lung Cell Mol Physiol; 2015 Nov; 309(10):L1037-40. PubMed ID: 26432873
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Endothelium-Derived C-Type Natriuretic Peptide Contributes to Blood Pressure Regulation by Maintaining Endothelial Integrity.
    Nakao K; Kuwahara K; Nishikimi T; Nakagawa Y; Kinoshita H; Minami T; Kuwabara Y; Yamada C; Yamada Y; Tokudome T; Nagai-Okatani C; Minamino N; Nakao YM; Yasuno S; Ueshima K; Sone M; Kimura T; Kangawa K; Nakao K
    Hypertension; 2017 Feb; 69(2):286-296. PubMed ID: 28049696
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The fibrate gemfibrozil is a NO- and haem-independent activator of soluble guanylyl cyclase: in vitro studies.
    Sharina IG; Sobolevsky M; Papakyriakou A; Rukoyatkina N; Spyroulias GA; Gambaryan S; Martin E
    Br J Pharmacol; 2015 May; 172(9):2316-29. PubMed ID: 25536881
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Sodium nitrite causes relaxation of the isolated rat aorta: By stimulating both endothelial NO synthase and activating soluble guanylyl cyclase in vascular smooth muscle.
    Ling WC; Lau YS; Murugan DD; Vanhoutte PM; Mustafa MR
    Vascul Pharmacol; 2015 Nov; 74():87-92. PubMed ID: 26044183
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mechanisms of nitric oxide independent activation of soluble guanylyl cyclase.
    Schmidt P; Schramm M; Schröder H; Stasch JP
    Eur J Pharmacol; 2003 May; 468(3):167-74. PubMed ID: 12754054
    [TBL] [Abstract][Full Text] [Related]  

  • 68. BAY 60-2770 activates two isoforms of nitric oxide sensitive guanylyl cyclase: Evidence for stable insertion of activator drugs.
    Sömmer A; Sandner P; Behrends S
    Biochem Pharmacol; 2018 Jan; 147():10-20. PubMed ID: 29155144
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Vasorin plays a critical role in vascular smooth muscle cells and arterial functions.
    Louvet L; Lenglet G; Krautzberger AM; Mentaverri R; Hague F; Kowalewski C; Mahtal N; Lesieur J; Bonnet AL; Andrique C; Gaucher C; Gomila C; Schrewe H; Tharaux PL; Kamel S; Chaussain C; Six I
    J Cell Physiol; 2022 Oct; 237(10):3845-3859. PubMed ID: 35892191
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Antagonism of Forkhead Box Subclass O Transcription Factors Elicits Loss of Soluble Guanylyl Cyclase Expression.
    Galley JC; Durgin BG; Miller MP; Hahn SA; Yuan S; Wood KC; Straub AC
    Mol Pharmacol; 2019 Jun; 95(6):629-637. PubMed ID: 30988014
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Loss of smooth muscle cell disintegrin and metalloproteinase 17 transiently suppresses angiotensin II-induced hypertension and end-organ damage.
    Shen M; Morton J; Davidge ST; Kassiri Z
    J Mol Cell Cardiol; 2017 Feb; 103():11-21. PubMed ID: 27993561
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Elevated pressure causes endothelial dysfunction in mouse carotid arteries by increasing local angiotensin signaling.
    Zhao Y; Flavahan S; Leung SW; Xu A; Vanhoutte PM; Flavahan NA
    Am J Physiol Heart Circ Physiol; 2015 Feb; 308(4):H358-63. PubMed ID: 25485905
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The NO-heme signaling hypothesis.
    Kleschyov AL
    Free Radic Biol Med; 2017 Nov; 112():544-552. PubMed ID: 28877508
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Deconstructing endothelial dysfunction: soluble guanylyl cyclase oxidation and the NO resistance syndrome.
    Gladwin MT
    J Clin Invest; 2006 Sep; 116(9):2330-2. PubMed ID: 16955136
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Different influences of extracellular and intracellular superoxide on relaxation through the NO/sGC/cGMP pathway in isolated rat iliac arteries.
    Tawa M; Shimosato T; Iwasaki H; Imamura T; Okamura T
    J Cardiovasc Pharmacol; 2015 Feb; 65(2):160-7. PubMed ID: 25329747
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cooperation between CYB5R3 and NOX4 via coenzyme Q mitigates endothelial inflammation.
    Yuan S; Hahn SA; Miller MP; Sanker S; Calderon MJ; Sullivan M; Dosunmu-Ogunbi AM; Fazzari M; Li Y; Reynolds M; Wood KC; St Croix CM; Stolz D; Cifuentes-Pagano E; Navas P; Shiva S; Schopfer FJ; Pagano PJ; Straub AC
    Redox Biol; 2021 Nov; 47():102166. PubMed ID: 34656824
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Anti-fibrotic effects of soluble guanylate cyclase stimulators and activators: A review of the preclinical evidence.
    Sandner P; Stasch JP
    Respir Med; 2017 Jan; 122 Suppl 1():S1-S9. PubMed ID: 28341058
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Nitric oxide- and heme-independent activation of soluble guanylate cyclase attenuates peroxynitrite-induced endothelial dysfunction in rat aorta.
    Korkmaz S; Loganathan S; Mikles B; Radovits T; Barnucz E; Hirschberg K; Li S; Hegedüs P; Páli S; Weymann A; Karck M; Szabó G
    J Cardiovasc Pharmacol Ther; 2013 Jan; 18(1):70-7. PubMed ID: 22914857
    [TBL] [Abstract][Full Text] [Related]  

  • 79. NO rapidly mobilizes cellular heme to trigger assembly of its own receptor.
    Dai Y; Faul EM; Ghosh A; Stuehr DJ
    Proc Natl Acad Sci U S A; 2022 Jan; 119(4):. PubMed ID: 35046034
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Carbon monoxide and hypertension.
    Ndisang JF; Tabien HE; Wang R
    J Hypertens; 2004 Jun; 22(6):1057-74. PubMed ID: 15167436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.